Recombinant Ferredoxin-2

Shipped with Ice Packs
In Stock

Description

Biological Role and Specificity

FDX2 is indispensable for mitochondrial Fe/S cluster biosynthesis, a process mediated by the ISC (iron-sulfur cluster) complex. Depletion of FDX2 in human cells severely impairs the activity of Fe/S-dependent enzymes (e.g., aconitases, respiratory complexes I and II) and disrupts cristae structure, leading to mitochondrial iron overload . Unlike FDX1, FDX2 cannot reduce cytochromes P450 or support steroidogenesis, highlighting its exclusive role in Fe/S protein maturation .

Recombinant Production and Purification

FDX2 is heterologously expressed in E. coli systems optimized for Fe/S cluster incorporation:

  • Expression: High yields (~23–40 mg/L) are achieved using E. coli C41(DE3) strains with iron/sulfur supplementation .

  • Purification: Affinity chromatography (Strep/His-tags) and anion-exchange chromatography yield functional FDX2 .

  • Validation: UV-Vis, CD spectroscopy, and EPR confirm intact [2Fe-2S] clusters .

Table 1: Impact of FDX2 C-Terminal Truncations on [2Fe-2S] Cluster Synthesis4

VariantΔC-Terminal ResiduesCluster Synthesis Rate (% of WT)Redox Potential (mV vs. SHE)
WT FDX20100%-180 ± 5
ΔC11400%-355 ± 10
ΔC55350%-350 ± 10
ΔC1010300%-340 ± 10
ΔC1212150%-320 ± 10

Truncations up to ΔC10 enhance synthesis rates, likely by reducing steric hindrance, while ΔC12 partially restores WT-like behavior .

Table 2: Enzyme Activities in FDX2-Depleted HeLa Cells5

EnzymeActivity (% of Control)
Mitochondrial Aconitase15%
Cytosolic Aconitase20%
Complex I10%
Cytochrome c Oxidase35%
Succinate Dehydrogenase25%

FDX2 depletion triggers cytosolic iron deficiency and mitochondrial iron accumulation, destabilizing Fe/S-dependent regulators like IRP1 .

Competitive Binding with Frataxin (FXN)

FDX2 and FXN compete for binding to the ISC complex’s Arg-rich region on NFS1 :

  • FDX2 titration: Maximal [2Fe-2S] synthesis occurs at 1–2 µM FDX2; higher concentrations inhibit activity due to FXN displacement .

  • FXN titration: Synthesis rates peak at 1 µM FXN and decline beyond 10 µM, reflecting competitive interplay .

Evolutionary Conservation and Fungal Orthologs

FDX2’s C-terminal motif (residues 173–175) is conserved across eukaryotes. Fungal ferredoxins (e.g., S. cerevisiae Yah1) functionally substitute FDX2 in human ISC assays, despite sequence divergence .

Therapeutic Implications

FDX2 mutations are linked to impaired Fe/S protein maturation and mitochondrial disorders. Targeting FDX2-FXN interactions could modulate cluster synthesis in diseases like Friedreich’s ataxia .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format by default. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary based on purchasing method and location. Contact your local distributor for specific delivery information. All proteins are shipped with standard blue ice packs. Request dry ice shipping in advance for an additional fee.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form generally has a 6-month shelf life at -20°C/-80°C. Lyophilized form generally has a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
Ferredoxin-2; Ferredoxin II; FdII
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-106
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Rhodospirillum rubrum
Target Protein Sequence
PYVVTENCIK CKYQDCVEVC PVDCFYEGEN FLVINPDECI DCGVCNPECP AEAIAGKWLE INRKFADLWP NITRKGPALA DADDWKDKPD KTGLLSENPG KGTVCH
Uniprot No.

Target Background

Function
Ferredoxins are iron-sulfur proteins that facilitate electron transfer in various metabolic reactions.

Q&A

Basic Research Questions

  • What is Ferredoxin-2 and what is its role in mitochondrial function?

    Ferredoxin-2 (FDX2) is a mitochondrial [2Fe-2S] cluster-containing protein that serves as an essential electron donor in the de novo assembly of iron-sulfur (FeS) clusters. FDX2 functions as a component of the mitochondrial iron-sulfur cluster (ISC) assembly machinery, working alongside the scaffold protein ISCU2, the cysteine desulfurase subcomplex NFS1-ISD11-ACP1, and the allosteric activator frataxin (FXN) .

    Unlike its paralog Ferredoxin-1 (FDX1/adrenodoxin), which primarily functions in steroidogenesis, FDX2 is crucially involved in both [2Fe-2S] and [4Fe-4S] cluster biosynthesis . This essential role makes FDX2 fundamental to numerous cellular processes dependent on FeS proteins, including respiration, DNA synthesis, and protein translation. Mutations in FDX2 are associated with iron accumulation in mitochondria and linked to several rare human diseases, including neurodegenerative conditions .

  • How can researchers express and purify functional recombinant Ferredoxin-2?

    Successful recombinant expression and purification of functional FDX2 requires strategic approaches to ensure proper [2Fe-2S] cluster incorporation. Based on research protocols, the following methods have proven effective:

    Expression Systems:

    • Escherichia coli is the predominant heterologous expression system for FDX2 production

    • Expression vectors providing strong promoter control (such as T7) optimize protein yield

    • The mature protein sequence (without mitochondrial targeting sequence) should be used

    Expression Strategy:

    • FDX2 can be expressed as a fusion protein to enhance solubility and facilitate purification

    • Expression at lower temperatures (16-25°C) often improves proper folding and [2Fe-2S] cluster incorporation

    • Supplementation of the growth medium with iron salts and incorporation of an anaerobic environment during late expression phases can enhance cluster assembly

    Purification Protocol:

    • Initial clarification through centrifugation following cell lysis

    • Sequential chromatography typically involving:
      a) Affinity chromatography (Ni-NTA for His-tagged proteins)
      b) Ion exchange chromatography (typically anion exchange)
      c) Size exclusion chromatography for final polishing

    • All purification steps should ideally be performed under anaerobic or low-oxygen conditions

    Successful expression typically yields a pink/reddish-colored protein solution, characteristic of [2Fe-2S] cluster-containing ferredoxins .

  • How can the proper incorporation and functionality of the [2Fe-2S] cluster in recombinant FDX2 be verified?

    Multiple complementary analytical techniques should be employed to verify proper [2Fe-2S] cluster incorporation and functionality:

    Spectroscopic Analysis:

    • UV-visible absorption spectroscopy: Properly folded FDX2 with intact [2Fe-2S] clusters shows characteristic absorption peaks with patterns distinctive of [2Fe-2S] ferredoxins

    • Circular dichroism (CD) spectroscopy: Provides information about both protein secondary structure and [2Fe-2S] cluster environment

    • Electron paramagnetic resonance (EPR) spectroscopy: The reduced [2Fe-2S]¹⁺ cluster is EPR-active, allowing confirmation of proper cluster coordination environment

    Functional Verification:

    • Electron transfer capacity: Assess reducibility by ferredoxin reductase (FDXR) using NADPH as electron donor

    • Functional assays: CD spectroscopy-based [2Fe-2S] cluster synthesis assays can monitor FDX2's ability to support cluster formation on ISCU2, measuring absorption at 431 nm

    Biochemical Characterization:

    • Redox potential determination: Provides information about the thermodynamic properties of the [2Fe-2S] cluster

    • Iron and sulfur content determination: Ideally showing a 2:2 Fe:S stoichiometry per protein monomer

  • What are the key structural and functional differences between Ferredoxin-2 and Ferredoxin-1?

    Despite their sequence similarity as [2Fe-2S] cluster-containing proteins, FDX1 and FDX2 exhibit critical differences:

    FeatureFerredoxin-1 (FDX1)Ferredoxin-2 (FDX2)
    Primary functionSteroidogenesis, cytochrome P450 reductionIron-sulfur cluster biogenesis
    Tissue expressionHighly expressed in adrenal gland, kidney, testesUbiquitously expressed across tissues
    Specific structural featuresLacks C-terminal motif found in FDX2Contains distinctive conserved C-terminus
    Electron acceptorsEfficiently reduces mitochondrial cytochromes P450Transfers electrons to ISC machinery
    Biochemical specificityUnable to efficiently support Fe/S protein biogenesisUnable to efficiently reduce cytochromes P450

    Quantitative analysis of tissue distribution found that Fdx1 and Fdx2 were present in HeLa cells at approximately 90 and 40 ng/mg cell protein, respectively . While both ferredoxins can accept electrons from NADPH via ferredoxin reductase (FDXR), they exhibit remarkable substrate specificity in their downstream electron transfer pathways.

  • What experimental approaches are used to study FDX2's role in iron homeostasis?

    FDX2 deficiency directly impacts cellular iron homeostasis through impaired Fe/S protein biogenesis. Researchers employ several approaches to study this relationship:

    Cellular Models:

    • RNA interference or CRISPR-based gene editing to deplete FDX2

    • Complementation studies with wild-type or mutant FDX2 variants

    • Cell lines with inducible FDX2 expression for temporal studies

    Iron Homeostasis Assessment:

    • Monitoring iron regulatory proteins (IRPs): FDX2 deficiency alters IRP1 and IRP2 mRNA binding activity

    • Measuring cellular iron uptake: FDX2 depletion increases iron uptake mechanisms

    • Analyzing mitochondrial iron accumulation: FDX2 deficiency leads to mitochondrial iron overload

    Functional Readouts:

    • Activity assays for Fe/S-dependent enzymes across cellular compartments

    • Quantification of iron-responsive element (IRE)-containing transcripts

    • Assessment of oxidative stress parameters associated with iron dysregulation

    These approaches have established that FDX2 deficiency has a severe impact on cellular iron homeostasis through impaired Fe/S protein biogenesis, leading to increased cellular iron uptake and pathological iron accumulation in mitochondria .

Advanced Research Questions

  • What are the structural determinants that govern FDX2 interaction with the core ISC complex?

    Cryo-EM structures, combined with biochemical studies, have revealed several key structural determinants mediating FDX2 interaction with the core ISC complex:

    Two-Stage Binding Model:
    FDX2 can bind the core ISC complex in two distinct conformations :

    a) Distal Conformation:

    • FDX2's helix F interacts electrostatically with an arginine patch on NFS1

    • The [2Fe-2S] cluster of FDX2 remains relatively distant from the ISCU2 assembly site

    • Represents an initial recognition and binding state

    b) Proximal Conformation:

    • Electrostatic interaction between FDX2 and NFS1 tightens

    • The FDX2-specific C-terminus binds to NFS1

    • The [2Fe-2S] cluster moves closer to the ISCU2 FeS cluster assembly site

    • Facilitates rapid electron transfer for FeS cluster assembly

    Critical Interaction Elements:

    • The C-terminal region of FDX2 binds specifically to NFS1 in the proximal conformation

    • Residue Asn175 of FDX2 forms hydrogen bonds with Ser385 of NFS1

    • Salt bridges form between FDX2 and NFS1 in both binding conformations

    Competitive Binding Dynamics:

    • FDX2 and frataxin (FXN) compete for overlapping binding sites on the core ISC complex

    • This competition influences the dynamics and efficiency of FeS cluster assembly

    These structural determinants collectively enable the specific binding of FDX2 to the core ISC complex and facilitate electron transfer necessary for FeS cluster assembly.

  • What is the significance of the conserved C-terminus of Ferredoxin-2 in its function?

    The conserved C-terminus of FDX2 plays several crucial roles in its function and specificity:

    Structural Basis of Specificity:

    • The C-terminal sequence distinguishes "type II ferredoxin" (FDX2) from type-I adrenodoxin (FDX1) and fungal-type eukaryotic [2Fe-2S] ferredoxins

    • This structural difference contributes to FDX2's specialization for FeS cluster biosynthesis

    Interaction with the ISC Complex:

    • In the proximal conformation, the C-terminus binds to NFS1

    • Key residues include Asn175, which forms hydrogen bonds with Ser385 of NFS1

    • This interaction appears important for the transition from distal to proximal binding

    Effect on Cluster Assembly Rates:
    Truncation experiments with variants lacking C-terminal residues revealed unexpected results:

    • All truncated variants (ΔC1, ΔC5, ΔC10, ΔC12) could generate wild-type amounts of [2Fe-2S] clusters

    • ΔC1, ΔC5, and ΔC10 variants showed up to fourfold higher cluster assembly rates than wild-type FDX2 under standard conditions (5 μM)

    • The ΔC12 variant showed a different kinetic profile with only 1.5-fold higher rates

    Site-Specific Mutational Evidence:

    • The FDX2-N175A mutant (replacing Asn with Ala) showed reduced efficiency in [2Fe-2S] cluster assembly at standard concentrations

    • FDX2-N175A required higher concentrations to achieve efficient cluster assembly, suggesting this residue is important but not essential

    Though not absolutely essential for in vitro [2Fe-2S] cluster assembly, the conserved C-terminus fine-tunes FDX2's interaction with the core ISC complex and influences the efficiency of FeS cluster biosynthesis.

  • How does FDX2 compete with frataxin (FXN) for binding to the core ISC complex?

    FDX2 and frataxin (FXN) exhibit a competitive relationship for binding to the core ISC complex that dynamically regulates FeS cluster assembly:

    Structural Basis of Competition:

    • Cryo-EM structures show that FDX2 and FXN binding sites on the core ISC complex partially overlap

    • This creates a physical basis for competition where simultaneous binding of both proteins at their optimal positions may be restricted

    Concentration-Dependent Effects:

    • FDX2 shows a bell-shaped concentration-dependence curve for [2Fe-2S] cluster synthesis:

      • Maximum rate occurs at approximately 1-2 μM FDX2

      • Rates decrease at higher FDX2 concentrations

    • FXN also exhibits bell-shaped concentration-dependence:

      • Maximum rate above 1 μM FXN

      • Little change up to 10 μM FXN

      • Substantial drop at 20 μM FXN

    Relative Binding Dynamics:

    • FXN requires much higher concentrations (>10 μM) to decrease cluster synthesis rates

    • This suggests FXN is a comparatively weaker competitor under turnover conditions

    • Optimal relative concentrations of both proteins are required for maximum synthesis rates

    Regulatory Implications:

    • The competition likely serves as a regulatory mechanism for coordinating the multiple steps of FeS cluster assembly

    • Alterations in the balance between FDX2 and FXN could affect the efficiency of FeS cluster biosynthesis

    • This competitive relationship has particular relevance for understanding Friedreich's ataxia, where decreased FXN function leads to neurodegeneration

    This competition suggests that FeS cluster assembly involves a precisely coordinated sequence of protein interactions rather than simultaneous binding of all components.

  • What spectroscopic methods are most effective for analyzing electron transfer in the context of FDX2-mediated FeS cluster assembly?

    Multiple spectroscopic techniques provide complementary insights into FDX2-mediated electron transfer:

    UV-Visible Absorption Spectroscopy:

    • Monitors redox state changes of FDX2's [2Fe-2S] cluster

    • Tracks cluster formation on ISCU2 during assembly

    • Can be performed in real-time to follow reaction progression

    • Particularly useful at wavelengths characteristic of [2Fe-2S] clusters (typically 330-460 nm)

    Circular Dichroism (CD) Spectroscopy:

    • Provides distinctive signals for [2Fe-2S] clusters in different environments

    • Used to monitor [2Fe-2S] cluster formation on ISCU2 at 431 nm

    • Can detect conformational changes accompanying electron transfer

    • Successfully employed in tracking FDX2-dependent reduction and cluster assembly

    Electron Paramagnetic Resonance (EPR) Spectroscopy:

    • Detects paramagnetic species including reduced [2Fe-2S]¹⁺ clusters

    • Can identify distinct intermediates during electron transfer

    • Provides detailed electronic structure information

    • Successfully used to characterize [2Fe-2S] cluster in recombinant ferredoxins

    Time-Resolved Techniques:

    • Stopped-flow spectroscopy: Measures rapid electron transfer kinetics

    • Rapid freeze-quench EPR: Captures transient intermediates

    • These approaches are particularly valuable for studying the sequential steps in electron transfer

    For effective experimental design, researchers should combine multiple spectroscopic methods with kinetic analyses, varying protein concentrations to identify rate-limiting steps and competition effects as demonstrated in studies with FDX2, FXN, and the core ISC complex .

  • How do mutations in the C-terminal region of FDX2 affect its function in FeS cluster assembly?

    The C-terminal region of FDX2 has been extensively studied through mutational analysis, revealing nuanced effects on FeS cluster assembly:

    Truncation Effects on Cluster Assembly:

    FDX2 VariantCluster Formation CapabilityRelative Rate (vs. WT)Concentration Dependence
    Wild-typeComplete1× (reference)Bell-shaped curve with max at 1-2 μM
    ΔC1CompleteUp to 4× higherSimilar to ΔC5/ΔC10
    ΔC5CompleteUp to 4× higherSimilar to ΔC1/ΔC10
    ΔC10CompleteUp to 4× higherSimilar to ΔC1/ΔC5
    ΔC12Complete~1.5× higherDistinct pattern requiring higher concentration

    Site-Specific Mutations:

    • FDX2-N175A (mutation of Asn175 to Ala):

      • Maintained ability to support [2Fe-2S] cluster assembly

      • Required higher concentrations for efficient function

      • Showed kinetic behavior similar to the ΔC12 variant

      • Demonstrates the importance of Asn175 in FDX2 function

    Mechanistic Insights:

    • C-terminal residues influence the transition between distal and proximal binding conformations

    • The unexpected increase in activity with certain truncations suggests complex regulatory roles

    • The salt bridge formed between Asp179 (FDX2) and Arg393 (NFS1) appears to have minor influence on synthesis rates

    • Asn175 forms hydrogen bonds with Ser385 of NFS1 in the proximal conformation, playing a key role in positioning FDX2 for efficient electron transfer

    Evolutionary Considerations:

    • The C-terminal sequence distinguishes "type II ferredoxin" (FDX2) from type-I adrenodoxin (FDX1)

    • Fungal-type ferredoxins (S. cerevisiae Yah1, C. thermophilum Yah1) with different C-termini can also support in vitro [2Fe-2S] cluster synthesis

    These findings demonstrate that while the C-terminus is not absolutely essential for basic FDX2 function, it serves to optimize interaction dynamics with the core ISC complex and fine-tune the efficiency of FeS cluster assembly.

  • What experimental approaches best characterize the two-stage binding model of FDX2 to the core ISC complex?

    The two-stage binding model (distal and proximal conformations) of FDX2 to the core ISC complex requires multifaceted experimental approaches:

    Structural Determination:

    • Cryo-electron microscopy (cryo-EM) has been instrumental in directly visualizing both conformational states

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) can map regions with different solvent accessibility in each conformation

    • Cross-linking mass spectrometry can identify distance constraints between interacting residues

    Mutational Analysis with Functional Readouts:

    • Site-directed mutagenesis targeting key residues in:

      • Electrostatic interfaces (helix F region interacting with NFS1)

      • C-terminal region critical for transition to proximal conformation

      • The Asn175 position shown to be important for interaction with NFS1

    • Functional assessment using:

      • CD spectroscopy-based [2Fe-2S] cluster synthesis assays

      • Concentration-dependent activity measurements

      • Competition assays with FXN

    Kinetic and Thermodynamic Studies:

    • Binding affinity measurements using surface plasmon resonance or isothermal titration calorimetry

    • Pre-steady-state kinetics to resolve transitions between binding states

    • Electron transfer rate measurements in different conformational states

    Computational Approaches:

    • Molecular dynamics simulations of the transition between distal and proximal states

    • Calculation of electrostatic interaction energies

    • Modeling of electron transfer pathways in both conformations

    Distance Measurements:

    • FRET-based approaches to measure distances between labeled components

    • EPR-based distance measurements (DEER/PELDOR) for paramagnetic centers

    Research has shown that the proximal conformation facilitates optimal positioning of the [2Fe-2S] cluster of FDX2 relative to the ISCU2 FeS cluster assembly site, enabling efficient electron transfer . The distal-to-proximal transition appears to be influenced by the C-terminal region, particularly residue Asn175.

  • How does the redox potential of FDX2 influence its electron transfer specificity in FeS cluster assembly?

    The redox potential of FDX2 is a critical determinant of its electron transfer capabilities and functional specificity:

    Thermodynamic Considerations:

    • The midpoint redox potential (E°') determines the thermodynamic driving force for electron transfer

    • For efficient electron transfer, the potential of FDX2 must be sufficiently negative to reduce its target in the ISC machinery

    • Related ferredoxins typically have negative redox potentials; for example, Rhodobacter capsulatus FdV has E°' = -220 mV at pH 7.5

    Functional Implications:

    • Too high (less negative) redox potential can limit electron donation capacity

    • Too low (more negative) potential might lead to non-specific electron transfer

    • The specific redox potential of FDX2 likely evolved to match precisely the requirements of the ISC machinery

    Specificity Determinants:

    • The distinct redox properties of FDX1 and FDX2 contribute to their specificity for different pathways:

      • FDX1: Optimized for electron transfer to cytochromes P450 in steroidogenesis

      • FDX2: Optimized for electron transfer in Fe/S cluster biosynthesis

    Experimental Approaches:

    • Protein engineering to alter redox potential through targeted mutations

    • Correlation of redox potential changes with functional outcomes in FeS cluster assembly

    • Spectroelectrochemical measurements to determine precise potential values in different protein contexts

    Physiological Relevance:

    • The matched redox properties between FDX2 and its electron acceptor in the ISC machinery ensure efficient and specific electron transfer

    • Environmental factors (pH, ionic strength) may modulate the effective redox potential in vivo

    • Redox potential differences between FDX2 and alternate electron donors explain their varying efficiencies in supporting FeS cluster assembly

    The precisely tuned redox potential of FDX2 represents an important mechanism for ensuring the specificity of electron flow in mitochondrial FeS cluster biogenesis.

  • What are the current methodological challenges in distinguishing FDX2's roles in [2Fe-2S] versus [4Fe-4S] cluster assembly?

    Distinguishing FDX2's potentially distinct roles in [2Fe-2S] versus [4Fe-4S] cluster assembly presents several methodological challenges:

    Spectroscopic Differentiation:

    • [2Fe-2S] and [4Fe-4S] clusters have overlapping spectroscopic features

    • Multiple complementary spectroscopic methods must be employed:

      • UV-visible spectroscopy

      • CD spectroscopy

      • EPR spectroscopy

      • Mössbauer spectroscopy for detailed iron site characterization

    Sequential Assembly Complexity:

    • [4Fe-4S] clusters often form via [2Fe-2S] cluster intermediates

    • Distinguishing direct effects on [4Fe-4S] assembly from indirect effects via [2Fe-2S] assembly is challenging

    • Temporal resolution in experimental design is critical

    Protein-Specific Readouts:

    • Using target proteins that specifically require either cluster type:

      • Ferredoxins (containing [2Fe-2S] clusters)

      • Aconitase or lipoate synthase (containing [4Fe-4S] clusters)

      • Monitoring assembly on these specific targets can help differentiate roles

    Isolation of Assembly Steps:

    • Development of in vitro systems that can separate [2Fe-2S] and [4Fe-4S] assembly steps

    • Selective inhibition of specific components in the [2Fe-2S] to [4Fe-4S] conversion pathway

    • Reconstitution approaches with defined components

    Genetic and Cellular Approaches:

    • Conditional depletion systems for FDX2 with time-course analysis

    • Complementation with FDX2 variants that might differentially affect [2Fe-2S] versus [4Fe-4S] assembly

    • Combined depletion of FDX2 with other factors specific to either pathway

    Addressing these challenges requires innovative experimental design, complementary methodologies, and careful interpretation of results to build a comprehensive understanding of FDX2's potentially distinct roles in assembling different types of FeS clusters.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.